We are live on ! Find out more
LKFT

Lakefront Biotherapeutics American Depositary Shares
LKFT

77 hedge funds and large institutions have $932M invested in Lakefront Biotherapeutics American Depositary Shares in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

12% more call options, than puts

Call options by funds: $634K | Put options by funds: $564K

12% more funds holding

Funds holding: 69 → 77 (+8)

4% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 26

0.32% less ownership

Funds ownership: 19.83% → 19.51% (-0.32%)

9% less capital invested

Capital invested by funds: $1.03B → $932M (-$95.2M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
77
Holders Change
+8
Holders Change %
+11.59%
% of All Funds
1.75%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
27
Reduced
26
Closed
8
Calls
$634K
Puts
$564K
Net Calls
+$70K
Net Calls Change
+$168K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$18.6M
2
Jane Street
Jane Street
New York
+$6.05M
3
CS
Credit Suisse
Switzerland
+$5.97M
4
FCM
Farallon Capital Management
California
+$5.09M
5
Millennium Management
Millennium Management
New York
+$4.29M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$27.6M
2
EC
EcoR1 Capital
California
-$12.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.03M
4
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$4.28M
5
OMC
Old Mission Capital
Illinois
-$3.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
Tekla Capital Management
Massachusetts
$4.99M +$3.24M +34,200 +180%
EAM
27
Eventide Asset Management
Massachusetts
$4.88M – – –
Millennium Management
28
Millennium Management
New York
$4.26M +$4.29M +45,404 New
DCM
29
DAFNA Capital Management
California
$3.71M +$757K +8,000 +25%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.7M -$129K -1,367 -3%
Arrowstreet Capital
31
Arrowstreet Capital
Massachusetts
$3.65M +$3.68M +38,952 New
AllianceBernstein
32
AllianceBernstein
Tennessee
$3.57M +$1.95M +20,640 +119%
JP Morgan Chase
33
JP Morgan Chase
New York
$2.5M -$304K -3,211 -11%
FPF
34
FNY Partners Fund
New York
$1.89M +$284K +3,000 +17%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$1.77M -$80.1K -847 -4%
Victory Capital Management
36
Victory Capital Management
Texas
$1.72M +$1.73M +18,296 New
ACM
37
Atika Capital Management
New York
$1.45M -$2.89M -30,500 -66%
PAWC
38
P.A.W. Capital
Connecticut
$1.13M +$189K +2,000 +20%
UC
39
Unterberg Capital
New York
$1.13M +$1.14M +12,000 New
FIM
40
Freedom Investment Management
Connecticut
$1.06M -$80.3K -849 -7%
JG
41
Jefferies Group
New York
$1.01M +$1.02M +10,745 New
Bank of America
42
Bank of America
North Carolina
$967K +$268K +2,831 +38%
Macquarie Group
43
Macquarie Group
Australia
$900K +$91.1K +963 +11%
AG
44
Aperio Group
California
$713K +$326K +3,444 +83%
CM
45
Castleark Management
Illinois
$635K -$294K -3,105 -31%
WJA
46
Williams Jones & Associates
New York
$623K -$2.37K -25 -0.4%
Geode Capital Management
47
Geode Capital Management
Massachusetts
$556K – – –
ProShare Advisors
48
ProShare Advisors
Maryland
$551K +$556K +5,875 New
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$488K +$225K +2,377 +84%
LCM
50
Landscape Capital Management
New Jersey
$388K +$84.6K +894 +28%
1
2
3 4

LKFT Hedge Fund Activity: Q4 2017 in Review

77 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q4 2017, worth a combined $932M — down 9.3% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new LKFT positions and 8 closed out — a net gain of 8 holders — while 27 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock, adding an estimated $18.6M. The largest seller was Fidelity Investments, cutting an estimated $27.6M.

  • 77 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q4 2017, up from 69 in Q3 2017.
  • Funds reported $932M of Lakefront Biotherapeutics American Depositary Shares stock for Q4 2017, down 9.3% quarter-over-quarter.
  • 16 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q4 2017 and 8 closed out, a net change of +8 holders.
  • The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q4 2017 was BlackRock, an estimated $18.6M added.
  • The largest Lakefront Biotherapeutics American Depositary Shares seller in Q4 2017 was Fidelity Investments, an estimated $27.6M sold.

Based on aggregated 13F filings for Q4 2017.